This information is over 2 years old. Information was current at time of publication.{"id":7192,"date":"2014-01-22T10:43:13","date_gmt":"2014-01-22T14:43:13","guid":{"rendered":"http:\/\/info.hsls.pitt.edu\/updatereport\/?p=7192"},"modified":"2014-02-05T10:07:00","modified_gmt":"2014-02-05T14:07:00","slug":"open-data-in-clinical-trials","status":"publish","type":"post","link":"https:\/\/info.hsls.pitt.edu\/updatereport\/open-data-in-clinical-trials\/","title":{"rendered":"Open Data in Clinical Trials"},"content":{"rendered":"<p>In a recent <i>New England Journal of Medicine<\/i> editorial titled, \u201c<a href=\"http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMe1400850\" target=\"_blank\">Open Data<\/a>,\u201d Jeffrey M. Drazen, MD, describes an Institute of Medicine (IOM) committee examining the sharing of data in clinical trials. The committee is charged with \u201creviewing current practices on data sharing in the context of randomized, controlled trials and with making recommendations for future data-sharing standards.\u201d<sup>1 <\/sup>\u00a0\u00a0A draft report of the committee\u2019s work can be found at <a href=\"http:\/\/www.iom.edu\/activities\/research\/sharingclinicaltrialdata.aspx\" target=\"_blank\">www.iom.edu\/activities\/research\/sharingclinicaltrialdata.aspx<\/a>.<\/p>\n<p>The committee is collecting comments on their draft report as well as comments about the sharing of clinical trial data. Comments will be collected until March 24, 2014, at <a href=\"http:\/\/www8.nationalacademies.org\/cp\/projectview.aspx?key=49578\" target=\"_blank\">www8.nationalacademies.org\/cp\/projectview.aspx?key=49578<\/a>.<\/p>\n<p>1. J.M. Drazen, \u201cOpen Data,\u201d <i>New England Journal of Medicine<\/i>, January 22, 2014, <a href=\"http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMe1400850\" target=\"_blank\">http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMe1400850<\/a>.<\/p>\n<p>~ Nancy Tannery<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In a recent New England Journal of Medicine editorial titled, \u201cOpen Data,\u201d Jeffrey M. Drazen, MD, describes an Institute of Medicine (IOM) committee examining the sharing of data in clinical trials. The committee is charged with \u201creviewing current practices on data sharing in the context of randomized, controlled trials and with making recommendations for future [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"issue-archives","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[61],"tags":[-1],"class_list":["post-7192","post","type-post","status-publish","format-standard","hentry","category-february-2014","avhec_catgroup-issue-archives"],"_links":{"self":[{"href":"https:\/\/info.hsls.pitt.edu\/updatereport\/wp-json\/wp\/v2\/posts\/7192","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/info.hsls.pitt.edu\/updatereport\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/info.hsls.pitt.edu\/updatereport\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/info.hsls.pitt.edu\/updatereport\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/info.hsls.pitt.edu\/updatereport\/wp-json\/wp\/v2\/comments?post=7192"}],"version-history":[{"count":5,"href":"https:\/\/info.hsls.pitt.edu\/updatereport\/wp-json\/wp\/v2\/posts\/7192\/revisions"}],"predecessor-version":[{"id":7204,"href":"https:\/\/info.hsls.pitt.edu\/updatereport\/wp-json\/wp\/v2\/posts\/7192\/revisions\/7204"}],"wp:attachment":[{"href":"https:\/\/info.hsls.pitt.edu\/updatereport\/wp-json\/wp\/v2\/media?parent=7192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/info.hsls.pitt.edu\/updatereport\/wp-json\/wp\/v2\/categories?post=7192"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/info.hsls.pitt.edu\/updatereport\/wp-json\/wp\/v2\/tags?post=7192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}